- Home
- IMPP vs ORMP Comparison
IMPP vs ORMP Comparison
Compare IMPP & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMPP | ORMP |
|---|---|---|
| Founded | 1981 | 2002 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.7M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMPP | ORMP |
|---|---|---|
| Price | $3.79 | $3.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 723.4K | 182.5K |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | ★ 1.03 | 1.03 |
| Revenue | ★ $136,071,654.00 | $2,000,000.00 |
| Revenue This Year | $7.55 | N/A |
| Revenue Next Year | $58.58 | N/A |
| P/E Ratio | $3.63 | ★ $3.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $1.82 |
| 52 Week High | $6.57 | $3.30 |
Technical Indicators
Market Signals| Indicator | IMPP | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 73.92 |
| Support Level | $3.63 | $2.75 |
| Resistance Level | $3.88 | $3.24 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 56.86 | 96.80 |
Price Performance
Historical ComparisonAbout IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.